Original language | English |
---|---|
Pages (from-to) | 2986-2999 |
Number of pages | 14 |
Journal | Journal of Cerebral Blood Flow and Metabolism |
Volume | 41 |
Issue number | 11 |
Early online date | 2 Jun 2021 |
DOIs | |
Publication status | Published - Nov 2021 |
Austrian Fields of Science 2012
- 301403 Neurochemistry
Keywords
- fMRI
- functional PET (fPET)
- PET/MRI
- task-specific activation
- test-retest reliability
- SIGNAL
- MRI
- SENSITIVITY
- REPRODUCIBILITY
- PERFUSION
- TEST-RETEST RELIABILITY
- PET
- FMRI
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Cerebral Blood Flow and Metabolism, Vol. 41, No. 11, 11.2021, p. 2986-2999.
Publications: Contribution to journal › Article › Peer Reviewed
TY - JOUR
T1 - Reliability of task-specific neuronal activation assessed with functional PET, ASL and BOLD imaging
AU - Rischka, Lucas
AU - Godbersen, Godber M.
AU - Pichler, Verena
AU - Michenthaler, Paul
AU - Klug, Sebastian
AU - Klöbl, Manfred
AU - Ritter, Vera
AU - Wadsak, Wolfgang
AU - Hacker, Marcus
AU - Kasper, Siegfried
AU - Lanzenberger, Rupert
AU - Hahn, Andreas
N1 - Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: M. Hacker received consulting fees and/or honoraria from Bayer Healthcare BMS, Eli Lilly, EZAG, GE Healthcare, Ipsen, ITM, Janssen, Roche, and Siemens Healthineers. S. Kasper received grants/research support, consulting fees and/or honoraria within the last three years from Angelini, AOP Orphan Pharmaceuticals AG, Celgene GmbH, Eli Lilly, Janssen-Cilag Pharma GmbH, KRKA-Pharma, Lundbeck A/S, Mundipharma, Neuraxpharm, Pfizer, Sage, Sanofi, Schwabe, Servier, Shire, Sumitomo Dainippon Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd. and Takeda. R. Lanzenberger received travel grants and/or conference speaker honoraria within the last three years from Bruker BioSpin MR, Heel, and support from Siemens Healthcare regarding clinical research using PET/MRI. He is a shareholder of BM Health GmbH since 2019. W. Wadsak declares to having received speaker honoraria from the GE Healthcare and research grants from Ipsen Pharma, Eckert-Ziegler AG, Scintomics, and ITG; and working as a part time employee of CBmed Ltd. (Center for Biomarker Research in Medicine, Graz, Austria). All other authors report no conflict of interest in relation to this study. Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded in whole, or in part, by the Austrian Science Fund (FWF) KLI 610, PI: Andreas Hahn. For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. L. Rischka and M. Klöbl are recipients of a DOC Fellowship of the Austrian Academy of Sciences at the Department of Psychiatry and Psychotherapy, Medical University of Vienna. S. Klug is supported by the MDPhD Excellence Program of the Medical University of Vienna. The scientific project was performed with the support of the Medical Imaging Cluster of the Medical University of Vienna. The sponsors were not involved in any part of the study. Acknowledgements Publisher Copyright: © The Author(s) 2021. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/11
Y1 - 2021/11
KW - fMRI
KW - functional PET (fPET)
KW - PET/MRI
KW - task-specific activation
KW - test-retest reliability
KW - SIGNAL
KW - MRI
KW - SENSITIVITY
KW - REPRODUCIBILITY
KW - PERFUSION
KW - TEST-RETEST RELIABILITY
KW - PET
KW - FMRI
UR - http://www.scopus.com/inward/record.url?scp=85107176367&partnerID=8YFLogxK
U2 - 10.1177/0271678X211020589
DO - 10.1177/0271678X211020589
M3 - Article
AN - SCOPUS:85107176367
SN - 0271-678X
VL - 41
SP - 2986
EP - 2999
JO - Journal of Cerebral Blood Flow and Metabolism
JF - Journal of Cerebral Blood Flow and Metabolism
IS - 11
ER -